Kirk AD - Search Results

1

The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.

Elster EA, Hale DA, Mannon RB, Cendales LC, Swanson SJ, Kirk AD. Elster EA, et al. Among authors: kirk ad. Transpl Immunol. 2004 Sep-Oct;13(2):87-99. doi: 10.1016/j.trim.2004.05.010. Transpl Immunol. 2004. PMID: 15380539 Review.

2

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.

Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, Fechner JH Jr, Germond RL, Kampen RL, Patterson NB, Swanson SJ, Tadaki DK, TenHoor CN, White L, Knechtle SJ, Harlan DM. Kirk AD, et al. Nat Med. 1999 Jun;5(6):686-93. doi: 10.1038/9536. Nat Med. 1999. PMID: 10371508

3

Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories.

Kirk AD. Kirk AD. Crit Rev Immunol. 1999;19(5-6):349-88. Crit Rev Immunol. 1999. PMID: 10647743 Review.

4

Hitting the reset button for immune tolerance.

Kirk AD. Kirk AD. Nat Med. 2001 Jan;7(1):24-5. doi: 10.1038/83304. Nat Med. 2001. PMID: 11135608

5

Potential of costimulation-based therapies for composite tissue allotransplantation.

Elster EA, Blair PJ, Kirk AD. Elster EA, et al. Among authors: kirk ad. Microsurgery. 2000;20(8):430-4. doi: 10.1002/1098-2752(2000)20:8<430::aid-micr14>3.0.co;2-k. Microsurgery. 2000. PMID: 11150995

6

Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.

Xu H, Elster E, Batty D, Berning J, Burkly L, Kampen R, Swanson S, Tadaki D, Harlan D, Kirk A. Xu H, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):223-4. doi: 10.1016/s0041-1345(00)01983-7. Transplant Proc. 2001. PMID: 11266788 No abstract available.

7

Primate skin allotransplantation with anti-CD154 monotherapy.

Elster EA, Xu H, Tadaki DK, Burkly LC, Berning JD, Baumgartner RE, Cruzata F, Patterson NB, Harlan DM, Kirk AD. Elster EA, et al. Among authors: kirk ad. Transplant Proc. 2001 Feb-Mar;33(1-2):675-6. doi: 10.1016/s0041-1345(00)02197-7. Transplant Proc. 2001. PMID: 11267012 No abstract available.

8

The role of CD154 in organ transplant rejection and acceptance.

Kirk AD, Blair PJ, Tadaki DK, Xu H, Harlan DM. Kirk AD, et al. Philos Trans R Soc Lond B Biol Sci. 2001 May 29;356(1409):691-702. doi: 10.1098/rstb.2001.0855. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11375072 Free PMC article. Review.

9

Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.

Kirk AD, Tadaki DK, Celniker A, Batty DS, Berning JD, Colonna JO, Cruzata F, Elster EA, Gray GS, Kampen RL, Patterson NB, Szklut P, Swanson J, Xu H, Harlan DM. Kirk AD, et al. Transplantation. 2001 Aug 15;72(3):377-84. doi: 10.1097/00007890-200108150-00005. Transplantation. 2001. PMID: 11502964

10

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

Elster EA, Xu H, Tadaki DK, Montgomery S, Burkly LC, Berning JD, Baumgartner RE, Cruzata F, Marx R, Harlan DM, Kirk AD. Elster EA, et al. Among authors: kirk ad. Transplantation. 2001 Nov 15;72(9):1473-8. doi: 10.1097/00007890-200111150-00001. Transplantation. 2001. PMID: 11707732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters